DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	59.87M 68.61M 55.21M 51.94M 96.93M 6.47B 97.76M 657M 255M 3.19B 257M 252M 11.07B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	42.28M 48.45M 38.99M 36.68M 68.45M 4.57B 69.04M 464M 180M 2.25B 182M 178M 7.82B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
09/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
13/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
28/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
15/04/21	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
30/12/20	DocCheck AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
30/12/20	DGAP-NVR : DocCheck AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	DJ

05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026
05-07	DocCheck : Jahresabschluss für das Geschäftsjahr 2025 und Lagebericht (DocCheck AG Einzelabschluss 31.12.2025 2)

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	31/07/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	31/07/2019

DocCheck AG Share Price BOERSE BERLIN

Stocks

ANWGn

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Managers and Directors: DocCheck AG

Other Healthcare Facilities & Services

Financials

Company Profile

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	14/12/2014
Winfried Leimeister BRD	Director/Board Member	-	31/12/1998
Karin Immenroth BRD	Director/Board Member	-	30/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	-.--%	-.--%	-	-	70.58M
CVS HEALTH CORPORATION	-0.85%	+0.31%	+46.55%	+45.19%	127B
HCA HEALTHCARE, INC.	-3.35%	+0.49%	+0.73%	+29.33%	86.11B
FRESENIUS SE & CO. KGAA	+0.69%	+4.30%	-8.60%	+52.01%	25.49B
QUEST DIAGNOSTICS INCORPORATED	-1.40%	-4.31%	+8.97%	+40.69%	21.89B
LABCORP HOLDINGS INC.	-1.44%	-4.77%	-1.40%	+9.20%	21.28B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.05%	+1.63%	-10.98%	-20.81%	20.33B
TENET HEALTHCARE CORPORATION	-3.32%	+4.73%	+3.05%	+120.03%	15.38B
REDE D'OR SÃO LUIZ S.A.	+0.39%	-2.32%	-5.73%	-0.60%	14.4B
DAVITA INC.	-1.27%	+4.72%	+52.30%	+112.98%	13.52B
Average	-1.05%	+2.25%	+9.43%	+43.11%	38.32B
Weighted average by Cap.	-1.45%	+2.07%	+18.40%	+39.42%

	2024	2025
Net sales	53.79M 61.64M 49.6M 46.66M 87.08M 5.81B 87.83M 591M 229M 2.86B 231M 226M 9.94B	55.32M 63.39M 51.01M 47.99M 89.55M 5.98B 90.33M 607M 235M 2.95B 238M 233M 10.23B
Net income	5.28M 6.05M 4.87M 4.58M 8.55M 571M 8.63M 58.02M 22.46M 281M 22.72M 22.23M 977M	5.33M 6.11M 4.92M 4.63M 8.64M 577M 8.71M 58.58M 22.68M 284M 22.94M 22.44M 986M
Net Debt	-20.11M -23.04M -18.54M -17.44M -32.55M -2.17B -32.83M -221M -85.48M -1.07B -86.47M -84.6M -3.72B	-17.59M -20.16M -16.22M -15.26M -28.48M -1.9B -28.72M -193M -74.78M -937M -75.64M -74.01M -3.25B